Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Photo: BSIP/UIG via Getty Images
Twenty-two countries are involved in a recall for a common heart drug, Valsartan, after it was discovered to have a chemical that "poses a potential cancer risk," CNN reports.
Why it matters: The impurity, Nitrosodimethylamine (NDMA), can "cause tumors in the liver, kidney and respiratory tract," as well as cause liver damage and "is a probable human carcinogen." While the amount of NDMA doesn't pose a "significantly increased risk," the company that developed the drug, Novartis, is encouraging patients to reach out to their doctors immediately. The countries affected include Germany, Norway, Finland, Sweden, Hungary, the Netherlands, Austria, Ireland, Bulgaria, Italy, Spain, Portugal, Belgium, France, Poland, Croatia, Lithuania, Greece, Canada, Bosnia and Herzegovina, Bahrain and Malta.